NanoTecNexus (NTN),
formerly NanoBioNexus, already acclaimed for its educational forums and nanobiotechnology
expertise, announces the launch of new courses, seminars, and lectures to be
delivered online with proven and easy to use webinar tools. The webinar series
initiative is part of NTN's strategy to reach broad geographically dispersed
communities, leverage scientific and business experts worldwide, and deliver
the highest caliber content in a cost-effective manner.
Kicking off the initiative is a first of its kind Continuing Medical Education
(CME) accredited webinar series entitled "Nanomedicine: New Strategies
and Innovations to Understand, Treat, and Monitor Disease" sponsored by
the UC San Diego School of Medicine and produced in partnership with the UC
San Diego NanoTumor Center (NTC). The first of six sessions is scheduled for
Friday November 20, at 11 am Pacific. Brochure and details follow.
The NanoTumor Center, a public-private consortium funded by the National Cancer
Institute Alliance for Nanotechnology and led by UC San Diego, is dedicated
to the translational application of nanotechnology in the fight against cancer.
NanoTecNexus, a member of this consortium and lead for the NTC educational projects,
led the planning committee in the design and organization of the webinar series
to meet the accreditation standards and requirements.
"Education in the new field of cancer nanotechnology for the scientific
and clinical communities as well as the general public is an integral part of
our center," said NTC Director Sadik Esener, PhD, Professor of Electrical
and Computer Engineering at the UCSD Jacobs School of Engineering.
"The public needs to be aware of and informed about progress in cancer
research in key fields such as nanotechnology," noted Dennis Carson, MD,
Director of the Moores UCSD Cancer Center, an NTC member. "These types
of educational projects are vital to its continued support and success."
The nanomedicine webinar series, the first of many to come, is designed for
the clinical and research
communities worldwide as well as industry professionals and general public
interested in learning about progress made in medical research. The goal is
to educate on the translational progress of applications using nanotechnology
to address disease. "We are committed to fill an important void and place
the attention on real progress, not just promise or hype," said Adriana
Vela, Founder and CEO of NanoTecNexus. "I am proud to say that, since our
inception, we have not wavered from delivering quality content." See brochure
at ntc-ccne.org/Seminars/nanomed/index.html
Additionally, industry and commercialization focused webinars are planned for
delivery in January 2010. Experts in topics ranging from nanotech venture financing
and the art of the term sheet to winning strategies for SBIR grant proposals
are among commercialization topics being planned. The industry focused segments
are designed for entrepreneurial and commercial companies as well as technology
and business professionals interested in nanotechnology opportunities. Visit
www.nanotecnexus.org for the latest webinar release dates.
Posted November 7th, 2009
